ESLA
ONMD
JTAI
ZURA

Owl Creek Asset Management, L.P.

Known title: 10% OwnerCIK: 0001313756

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

ESLA Among 12 Health Care Stocks Moving in Friday Pre‑Market. ESLA was one of 12 health‑care shares that saw movement in Friday’s pre‑market session. The stock traded with a volume spike and an RSI of 21.5, indicating a potential shift in interest. It remains near its 17‑touch support level of $0.74. The move comes as the broader health‑care sector shows early activity ahead of the trading day.

this person other insiders at ESLA

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split. OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.

this person other insiders at ONMD

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

JTAI noted in after‑market moves among industrial stocks. Jet.AI was listed among twelve industrial stocks that moved in Tuesday’s after‑market session. The activity shows the share attracted attention outside regular trading hours. The move occurs while the price is near its $0.62 support level and the RSI is around 40, indicating modest momentum.

this person other insiders at JTAI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

Zura Bio Named Top Pick by Guggenheim Amid Recent Price Gains. Zura Bio was highlighted as a top pick by Guggenheim, contributing to its recent upward movement alongside other stocks. The company's share price has risen, though it remains well below the average analyst target of $18.00. Current trading levels sit near the lower end of its 52-week range, reflecting a significant gap between current market price and long-term valuation estimates.

this person other insiders at ZURA

Transaction History

ESLA▼ Sell$2.8M
ONMD▼ Sell$5.2M
JTAI▼ Sell$1.1M
ZURA▼ Sell$5.7M

We use analytics to understand how market-wall is used. No personal data is sold.